RCBTB1 inhibitors are a class of chemical compounds that specifically target and inhibit the function of the RCBTB1 (Regulator of Chromosome Condensation and BTB Domain-Containing Protein 1) protein. RCBTB1 is part of the BTB (Broad-Complex, Tramtrack, and Bric-à-brac) domain-containing protein family, which plays a role in various cellular processes such as protein-protein interactions, ubiquitination, and chromatin remodeling. RCBTB1 is known to participate in the regulation of chromosome condensation, which is critical during the cell cycle and for maintaining genomic stability. By interfering with the activity of RCBTB1, these inhibitors can modulate cellular functions related to gene expression and cell cycle control, potentially altering how cells progress through stages of growth and division. The BTB domain itself is a versatile structural motif that allows for the formation of complexes with other proteins, suggesting that RCBTB1 inhibitors may affect a wide array of signaling pathways through their impact on protein interactions.
In terms of chemical design, RCBTB1 inhibitors can vary widely in structure, but their functional core typically includes motifs that enable specific binding to the RCBTB1 protein. Many of these inhibitors rely on non-covalent interactions, such as hydrogen bonding, hydrophobic interactions, and van der Waals forces, to achieve selectivity and potency. The structural specificity of these inhibitors is essential for selectively targeting the BTB domain without affecting other proteins that contain similar motifs. Additionally, the development of these inhibitors requires a thorough understanding of the protein's three-dimensional conformation and the binding pocket architecture, often guided by computational modeling and X-ray crystallography. These tools aid in optimizing the binding affinity and specificity of RCBTB1 inhibitors, making them valuable tools for studying the fundamental biological roles of this protein in cellular function and chromatin regulation.
SEE ALSO...
Items 1 to 10 of 17 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D inhibits transcription by intercalating into DNA, potentially preventing the transcription of the RCBTB1 gene. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor that can modulate chromatin structure and gene expression, potentially impacting the expression of the RCBTB1 gene. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By altering DNA methylation, these inhibitors can affect gene expression, potentially influencing RCBTB1. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide inhibits protein synthesis, potentially leading to reduced expression of RCBTB1 at the translational level. | ||||||
Puromycin dihydrochloride | 58-58-2 | sc-108071 sc-108071B sc-108071C sc-108071A | 25 mg 250 mg 1 g 50 mg | $42.00 $214.00 $832.00 $66.00 | 394 | |
Puromycin can cause premature chain termination during translation, potentially reducing the expression of RCBTB1 at the protein synthesis level. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin affects numerous signaling pathways and could indirectly modulate RCBTB1 function or expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Involved in gene expression and cell differentiation, Retinoic Acid might indirectly impact RCBTB1. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
α-Amanitin inhibits RNA polymerase II, a key enzyme in eukaryotic mRNA synthesis, potentially leading to reduced transcription of the RCBTB1 gene. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG can influence epigenetic mechanisms and signaling pathways, potentially affecting RCBTB1. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Influences various signaling pathways and might indirectly affect RCBTB1. | ||||||